)
)
Reata Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Reata Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Reata Pharmaceuticals Inc
Access all reports
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes innovative medicines in the areas of inflammation and immunology. The company is focused on discovering, developing, and commercializing novel therapeutics for patients with immune-mediated inflammatory diseases. The company has different phase II and phase III product candidates.
Latest articles
)
House of Warhammer: The Inner Workings of Games Workshop
A look under the hood of Games Workshop, a high-margin business in an incredibly niche market, with sky-high stock returns.
15 Nov 2024
)
Crafting a Solid Equity Story: A Strategic Guide for Investor Relations Professionals
Craft a compelling equity story: Align narratives with data to attract ideal investors and build trust with Quartr Pro's powerful IR tools.
13 Nov 2024
)
Our List of 100 Eminent Serial Acquirers
Serial acquirers have deep experience in mastering value creation through reallocating resources across their portfolio of acquired companies.
12 Nov 2024
Ticker symbol
RETA
Country
🇺🇸 United States